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A yedU gene product with a molecular mass of 31 kDa is a
hypothetical protein with no known function. The protein was
puri®ed and crystallized at 296 K. X-ray diffraction data have been
collected to 2.3 AÊ using synchrotron radiation. The crystals belong
to the primitive orthorhombic system, with unit-cell parameters
a = 50.56, b = 63.45, c = 168.02 AÊ . The asymmetric unit contains two
monomers of the protein, with a corresponding VM of 2.25 AÊ
3 Daÿ1
and a solvent content of 44.84%.
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1. Introduction
The nucleoid-associated protein H-NS, which
is encoded by the gene hns, has a central role in
the structuring and control of the enteric
bacterial chromosome (Williams, 1997). The
major role of H-NS is to modulate the
expression of a large number of unlinked genes
(Atlung & Ingmer, 1997). H-NS regulates the
expression of proVWX, bgl, appY and ®mB of
Escherichia coli (Atlung et al., 1996; Donato et
al., 1997; Higgins et al., 1998) and also affects
expression of some virulence genes of Salmo-
nella typhimurium and Shigella spp. (Maurelli
& Sansonetti, 1988; Harrison et al., 1994;
O'Byrne & Dorman, 1994). In an hns-deletion
background, the expression of numerous E. coli
cellular proteins is either strongly induced or
repressed relative to the levels in wild-type
cells (Bertin et al., 1990; Yamada et al., 1991). It
is thus suspected that H-NS may function as a
global transcriptional regulator.
The expression of an E. coli 31 kDa protein
(yedU gene product; YedU) has previously
been demonstrated to be greatly enhanced in
an hns-deletion background (Yoshida et al.,
1993). However, no physiological effect of the
enhancement or biochemical function of the
protein has yet been identi®ed. Although a
BLAST (Altschul et al., 1997) database search
revealed YedU to be composed of a domain
that is evolutionarily conserved from archea
to eukarya, the function of the protein still
remains obscure. According to PFAM
(Bateman et al., 1999), proteins containing the
domain are classi®ed as belonging to the ThiJ/
PfpI family, which contains many hypothetical
proteins. Even the functional members of the
family have distinct functions. This family
includes proteins involved in the regulation of
RNA±protein interactions (Hod et al., 1999),
thiamine biosynthesis (ThiJ; EC 2.7.1.49;
Mizote et al., 1996), Ras-related signal trans-
duction pathways (Nagakubo et al., 1997),
sperm fertility (Welch et al., 1998), de novo
synthesis of purine nucleotides (FGAM
synthase I from Sulfolobus solfataricus) and
protease activity (Halio et al., 1996) according
to the InterPro description of the family
(Apweiler et al., 2001). The domain is found at
the N-terminus of AraC-like transcriptional
regulators (Redenbach et al., 1996) and the
C-terminus of HPII-type calatases (Navarro
et al., 1996). The domain also appears to
be distantly related to glutamine amido-
transferases (Du et al., 2000; Horvath &
Grishin, 2001). The role of the domain is
therefore unclear, which prevents the identi®-
cation of the biological function of YedU from
the primary sequence.
In general, extensive biochemical and
physiological studies are required to determine
the biological functions of hypothetical
proteins. Recently, protein structures have
been used to assign the molecular functions of
hypothetical proteins, as the function of a gene
product is closely related to its three-dimen-
sional structure. Structural homologues of a
hypothetical protein are searched for in the
Protein Data Bank and the hypothetical
protein is then predicted to have molecular
functions similar to its homologues. The
predictions can provide a basis for assigning a
molecular function to the hypothetical protein.
For instance, Zarembinski et al. (1998), Hwang
et al. (1999) and Lee et al. (2001) have
succeeded in structure-based assignment of the
molecular function of hypothetical proteins.
The overall conformation, detection of the
active site and the amino-acid composition of
the active site, which can be revealed from the
structure of YedU, would lead us to the eluci-
dation of its biochemical function. Here, we
report the overexpression, crystallization and
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preliminary X-ray crystallographic analysis
of YedU as a ®rst step toward its structure
determination.
2. Preparation of recombinant YedU
The yedU gene coding for a 286 amino-acid
polypeptide was ampli®ed by the poly-
merase chain reaction using E. coli genomic
DNA as a template. The gene was inserted
downstream of the T7 promoter of the
expression plasmid pET-21b (Novagen) and
the plasmid was introduced into E. coli
strain BL21 (DE3). Cells were grown to an
OD600 of approximately 0.5 in Luria±Bertani
media containing 0.1 mg mlÿ1 ampicillin
(Duchefa) at 310 K and the expression of
YedU was induced by 1 mM isopropyl--
d-thiogalactoside (Duchefa). After 3 h
induction, cells were harvested and resus-
pended in 20 mM sodium phosphate pH
7.6 containing 1 mM dithiothreitol (Sigma).
After sonication and subsequent centrifu-
gation, the supernatant was loaded onto a
nickel±nitrilotriacetic acid column (Qiagen)
and the protein was eluted with a 0±500 mM
imidazole (Fluka) gradient in 20 mM sodium
phosphate pH 7.6 (Fluka). YedU was
further puri®ed using a Superdex 200 HR
16/60 molecular-sizing column (Amersham
Pharmacia Biotech) with 20 mM sodium
phosphate pH 7.6 and was then concen-
trated to approximately 12 mg mlÿ1 for
crystallization.
3. Crystallization and X-ray analysis
Crystals of YedU were obtained by the
hanging-drop vapour-diffusion method
using 24-well Costa plates at 296 K. The ®rst
crystallization screening was performed with
Crystal Screen, a sparse-matrix screening kit
(Hampton Research, USA). A number of
microcrystals were produced in a condition
containing 30% polyethyleneglycol 1500
(PEG 1.5K, Fluka) in 1 d. Subsequently, the
initial crystallization condition was opti-
mized to produce larger single crystals in
droplets containing 2 ml of protein sample
(12 mg mlÿ1) and an equal volume of
precipitant solution containing 26% PEG
1.5K. The droplets were equilibrated against
1 ml of the same precipitant solution at
296 K and the crystals grew to maximum size
in a week (0.01  0.01 0.1 mm; Fig. 1). For
data collection, crystals were frozen at 100 K
using a Cryostream cooler (Oxford Cryo-
systems) after brie¯y being immersed in a
cryoprotectant solution containing 15%
glycerol in the same precipitant solution. A
2.3 AÊ data set (Table 1) was obtained using a
MacScience DIP2030b imaging plate at
beamline 6B at the Pohang Light Source
(PLS), Korea. Using an autoindexing
program provided with the program HKL
(Otwinowski, 1993) and examining the
diffraction data set, we found that the crys-
tals belong to the primitive orthorhombic
system. Two molecules of YedU were
contained in the asymmetric unit, corre-
sponding to a crystal volume per unit
molecular weight (VM) of 2.25 AÊ
3 Daÿ1, with
a solvent content of 44.84% (Matthews,
1968). However, NCS (non-crystallographic
symmetry) was not detectable from a self-
rotation function. This happens, for instance,
if the NCS runs parallel to a crystallographic
symmetry axis or if the NCS is purely
translational.
4. Discussion
Two members of the ThiJ/PfpI family,
Pyrococcus horikoshii intracellular protease
PH1704, with 90% sequence identity to
P. furiosus PfpI (referred to hereafter as
PfpI), and E. coli HPII catalase, have been
studied structurally (Bravo et al., 1995; Du et
al., 2000). PfpI and the C-terminal ThiJ/PfpI
domain of the catalase show 25.9% (Fig. 2)
and 19.5% sequence identity to YedU,
respectively. Interestingly, two catalytic
residues (Cys100 and His101) of the
protease are well conserved in YedU, while
the C-terminal ThiJ/PfpI domain of the
catalase lacks these functional residues. The
sequence around the cysteine residue in
both proteins (SLCHGP in YedU and
SICHGP in the protease) is consistent with
the consensus sequence small-x-Nu-x-small-
small for / hydrolases (Du et al., 2000),
indicating that the two proteins may be
closely related in structure and function. The
crystal structure of P. horikoshii PH1704
reveals that PfpI-type proteases are homo-
hexameric proteases, which is consistent
with the experimental observation that
activity was found only for the oligomeric
forms of the protein (Du et al., 2000).
Molecular replacement was attempted using
AMoRe (Navaza, 1994) and CNS (BruÈ nger
et al., 1998) with monomeric and dimeric
models generated from the hexameric PfpI
Figure 1
Orthorhombic crystals of YedU from E. coli.
Table 1
Crystal information and data-collection statistics.
Values in parentheses refer to the highest resolution
shell, 2.30±2.38 AÊ .
Source 6B, PLS
Wavelength (AÊ ) 1.009
Space group P222 or P21212
Unit-cell parameters (AÊ ) a = 50.6, b = 63.5,
c = 168
Resolution range (AÊ ) 10.0±2.3
Completeness (>1, %) 95.4 (78.6)
Rsym² (%) 9.4 (33.7)
I/(I) 15.26 (2.8)
² Rsym =
P jIobs ÿ Iavgj=Iobs.
Figure 2
CLUSTALW sequence alignment between YedU and PfpI. PfpI exhibits the highest sequence similarity (25.9%
identity) to YedU among ThiJ/PfpI family members. *, : and . indicate perfect match, high similarity and low
similarity, respectively.
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structure. However, all trials resulted in
failure. The hexameric conformation of the
protease (a dimer of trimers) cannot be
applied to YedU because of the ortho-
rhombic symmetry of the YedU crystal with
two monomers in an asymmetric unit. The
formation of the catalytic triad in PfpI is
based on the hexameric conformation:
Cys100 and His101 form the triad with a
glutamate residue from an adjacent
monomer. As YedU appears to have a
distinct oligomeric conformation, it cannot
form the same catalytic triad as PfpI.
Therefore, the quaternary structures and
local conformation of the active sites of
YedU and PfpI must be quite different from
each other. In addition, YedU has about 100
more amino acids than PfpI, most of which
are at the N-terminus of YedU (Fig. 2).
Therefore, we cannot precisely infer the
structure and biochemical function of YedU
from those of PfpI. As an approach to
assigning the molecular structure and func-
tion of YedU, efforts toward structure
determination using MAD with SeMet-
YedU crystals are in progress. Structural
comparison between YedU and other
members of the ThiJ/PfpI family will also
contribute to determining the evolutionary
relationship between ThiJ/PfpI family
members of diverse biological functions that
share the common domain.
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